PKA inhibitor fragment (6-22) amide is the shortest synthetic PKI peptide, and acts as a potent protein kinase A (PKA) inhibitor.
CAT No: R0953
CAS No:121932-06-7
Synonyms/Alias:121932-06-7;L-Isoleucinamide, L-threonyl-L-tyrosyl-L-alanyl-L-alpha-aspartyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-serylglycyl-L-arginyl-L-threonylglycyl-L-arginyl-L-arginyl-L-asparaginyl-L-alanyl-;Tyadfiasgrtgrrnai-nh2;MFCD00133792;HB0508;AKOS024456843;C80H130N28O24;DA-76934;FP111129;PKA Inhibitor (6-22) amide trifluoroacetate salt;PKA Inhibitor 6-22 Amide - CAS 121932-06-7;H-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2; H-TYADFIASGRTGRRNAI-NH2;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.